PubMed ID:
22339929
Public Release Type:
Journal
Publication Year: 2012
Affiliation: Mayo Clinic, Rochester, MN 55905, USA.
DOI:
https://doi.org/10.1111/j.1365-2982.2012.01894.x
Authors:
Hamilton FA,
Grover M,
Bernard CE,
Pasricha PJ,
Lurken MS,
Faussone-Pellegrini MS,
Smyrk TC,
Parkman HP,
Abell TL,
Snape WJ,
Hasler WL,
McCallum RW,
Nguyen L,
Koch KL,
Calles J,
Lee L,
Tonascia J,
Ünalp-Arida A,
Farrugia G,
NIDDK Gastroparesis Clinical Research Consortium (GpCRC),
Pasricha PJ,
Nguyen L,
Ullah N,
Snape W,
Bishop R,
DeVole N,
Greene M,
Louiseau S,
Parker S,
Pillor E,
Ponsetto C,
Shetler K,
Farrugia G,
Grover M,
Bernard C,
Lurken M,
Shen K,
Sarr M,
Kendrick M,
Parkman HP,
Kantor S,
Lytes V,
Palit A,
Sachdeva P,
Simmons K,
Harbison S,
McCallum RW,
Hejazi R,
Sarosiek I,
Vasquez D,
Vega N,
Hasler W,
Atkinson M,
Abell T,
Fordham J,
Henry O,
Kedar A,
McNair V,
Spree D,
Koch K,
Baxter L,
Calles J,
Culler S,
Hooker J,
Stuart P,
Hamilton F,
James S,
Torrance R,
Van Raaphorst R,
Tonascia J,
Belt P,
Donithan M,
Green M,
Isaacson M,
Lee L,
May KP,
Miriel L,
Ünalp-Arida A,
Van Natta M,
Vaughn I,
Wilson L,
Yates K
Studies:
Gastroparesis Clinical Research Consortium
,
Nortriptyline for Idiopathic Gastroparesis
Cellular changes associated with diabetic (DG) and idiopathic gastroparesis (IG) have recently been described from patients enrolled in the Gastroparesis Clinical Research Consortium. The association of these cellular changes with gastroparesis symptoms and gastric emptying is unknown. The aim of this study was to relate cellular changes to symptoms and gastric emptying in patients with gastroparesis.